Off-label use refers to prescribing an FDA-approved drug for a purpose, dose, or population outside what it was officially approved for. This is legal and common in medicine, but insurers often will not cover off-label prescriptions — a relevant issue for GLP-1 drugs approved for diabetes but prescribed for weight loss, or vice versa, depending on the specific product's approval.